Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:09 AM
Ignite Modification Date:
2025-12-25 @ 10:09 PM
NCT ID:
NCT00251758
Pre Assignment Details:
Subjects with endoscopically documented normal esophageal mucosa were enrolled in Dexlansoprazole Modified Release (MR) or Placebo once daily (QD) treatment group; subjects were instructed that lifestyle or behavioral modifications designed to treat their symptoms of Gastroesophageal Reflux Disease (GERD) should not be altered throughout the study.
Recruitment Details:
Subjects enrolled at 157 sites in the United States (75 in Study T-GD04-082 \[NCT00251745\] and 82 in Study T-GD04-083 \[this posting, NCT00251758\]; date of first dose: 07 December 2005; date of last procedure: 23 May 2006).
Study:
NCT00251758
Study Brief:
Results Section:
NCT00251758